We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer.
- Authors
Claessens, Anouk K. M.; Busschbach, Jan J. V.; Ramaekers, Bram L. T.; Erdkamp, Frans L. G.; Bouma, Jeanette M.; van Leeuwen-Stok, A. Elise; Tjan-Heijnen, Vivianne C. G.; Bos, Monique E. M. M.
- Subjects
NETHERLANDS; BREAST cancer prognosis; THERAPEUTIC use of antineoplastic agents; DRUG efficacy; STATISTICS; CANCER chemotherapy; ANTINEOPLASTIC agents; MEDICAL care costs; MANN Whitney U Test; CANCER patients; COMPARATIVE studies; MEDICAL care use; COST effectiveness; SURVIVAL analysis (Biometry); QUALITY of life; QUESTIONNAIRES; DESCRIPTIVE statistics; HOSPITAL care; DATA analysis software; BEVACIZUMAB; PACLITAXEL; DATA analysis; RADIOTHERAPY; SENSITIVITY &; specificity (Statistics); BREAST tumors; QUALITY-adjusted life years
- Publication
Acta Oncologica, 2022, Vol 61, Issue 5, p619
- ISSN
0284-186X
- Publication type
Letter
- DOI
10.1080/0284186X.2022.2033832